Clinical trials are medical research studies that look for new ways to prevent, detect or treat disease. They’re used to determine if new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find effective new treatments. There are many kinds of clinical trials. Some test new drugs, while others look at new surgical procedures or devices, and still others look for new ways to use current treatments.
Are You Eligible?
Clinical trials have eligibility requirements, which may include your age, gender, other medical conditions and treatment history. If your doctor thinks you’re a good candidate, he or she will explain the study, what its benefits and risks are and possible side effects of the experimental treatment.
At Montefiore Nyack Hospital, patients who choose to participate in a clinical trial receive comprehensive, advanced care, sometimes well before it’s available anywhere else.
If you participate in a clinical trial, you might receive a new treatment that works better than existing treatments, and you’ll have extra care and attention from the medical research staff. Your quality of life and/or medical outcome might improve as a result of your participation in the trial. In addition, by participating in a clinical trial you’ll help improve the care of future patients. View our current clinical trials below.
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial.
MammaPrint, BluePrint and Full-Genome Data Linked With Clinical data to Evaluate New Gene Expression Profiles. An Adaptable Registry.
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Pembrolizumab Plus Chemo vs. Placebo Plus Chemo for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49).
Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer.
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer.
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT).
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair.
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer.
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer (SOLARIS).
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia.
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer.
Study in Subjects With Relapsed/Refractory Follicular Lymphoma.
A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy (CASPAR).